- Home
- Contact lenses
Contact lenses
“I’m a scientist dedicated to bringing eye-health innovations to the world”
Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
How Johnson & Johnson is Using Technology To Revolutionize the Way We Live and Work
The company now has more Lighthouse designations than any other—a marker of its excellence in manufacturing innovation. Learn how Johnson & Johnson sites are improving how and when we get the healthcare products and services we need and serving as a beacon to other manufacturers worldwide.
The power of prioritizing your vision
The idea of sight loss can be scary—but prompt diagnosis by an eye specialist can, in many cases, help preserve vision. For Healthy Vision Month, let these two patient stories inspire you to take action and schedule your checkup.
3 cutting-edge eye lenses designed to help improve how you see
Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.
Taking a trip back in time: 10 ways Johnson & Johnson has helped make vacationing easier since 1887
Packing the right essentials can make or break your summer getaway. But did you know many of those must-haves have been Johnson & Johnson innovations?
Contact lenses that darken when exposed to light? Check out the new Acuvue® Oasys with Transitions™ Light Intelligent Technology™
The innovative contact lenses change from clear to dark in less than a minute, helping your eyes adjust to fluctuating light conditions, while also blocking out harmful UV rays. A scientist explains how it all works.
Acuvue Oasys® with Transitions™ Light Intelligent Technology™ contact lenses named one of Time’s Best Inventions of 2018
This first-of-its-kind innovation has a dynamic photochromic filter that responds to changing light conditions.
Johnson & Johnson’s new Chief Financial Officer answers 7 popular investor questions
Joe Wolk, who has enjoyed a 20-year tenure at Johnson & Johnson, shares his vision for the company’s fiscal future.
Got dry eye? There’s a new treatment for that
Thirty million Americans suffer from Meibomian gland dysfunction, which causes the majority of dry eye cases. Learn how the LipiFlow® Thermal Pulsation System can help address it—in the blink of an eye.
5 rules of healthy vision everyone should follow
We asked eye care experts to share their top tips for keeping your baby blues (or browns or greens) well cared for year-round.